XML 17 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Guarantor (Tables)
 3 Months Ended
Mar. 31, 2014
Condensed Consolidating Financial Information  
Condensed Balance Sheet
Condensed Consolidating Balance Sheet - March 31, 2014 (In thousands)
GuarantorNon-GuarantorConsolidatingTotal
Parent IssuerSubsidiariesSubsidiariesAdjustmentsConsolidated
Assets
Current assets:
Cash and cash equivalents $ 5,562$ - $ 41,554$ - $ 47,116
Accounts receivable, net - - 106,209 - 106,209
Supplies inventory 52 - 18,381 - 18,433
Deferred income taxes 1,026 - - - 1,026
Prepaid and other current assets 28,618 - 13,350 (4,817) 37,151
Total current assets 35,258 - 179,494 (4,817) 209,935
Property and equipment, net 10,129 - 158,877 - 169,006
Investments in unconsolidated affiliates and other 1,489,635 1,458,185 - (2,928,336) 19,484
Goodwill and intangible assets, net 20,185 - 909 1,764,622 1,785,716
Total assets $ 1,555,207$ 1,458,185$ 339,280$ (1,168,531)$ 2,184,141
Liabilities and Equity
Current liabilities:
Current portion of long-term debt $ 10,714$ - $ 9,571$ - $ 20,285
Accounts payable 1,014 - 28,972 (4,627) 25,359
Accrued liabilities 24,092 - 14,703 (190) 38,605
Total current liabilities 35,820 - 53,246 (4,817) 84,249
Long-term debt 543,750 - 52,009 (30,822) 564,937
Deferred income taxes 185,882 - - - 185,882
Other long-term liabilities 7,342 - 18,411 - 25,753
Noncontrolling interests – redeemable - - 63,691 113,992 177,683
Equity:
Total AmSurg Corp. equity 782,413 1,458,185 113,448 (1,571,633) 782,413
Noncontrolling interests – non-redeemable - - 38,475 324,749 363,224
Total equity 782,413 1,458,185 151,923 (1,246,884) 1,145,637
Total liabilities and equity $ 1,555,207$ 1,458,185$ 339,280$ (1,168,531)$ 2,184,141
Condensed Consolidating Balance Sheet - December 31, 2013 (In thousands)
GuarantorNon-GuarantorConsolidatingTotal
Parent IssuerSubsidiariesSubsidiariesAdjustmentsConsolidated
Assets
Current assets:
Cash and cash equivalents $ 6,710$ -$ 44,130$ -$ 50,840
Accounts receivable, net - - 105,072 - 105,072
Supplies inventory 33 - 18,381 - 18,414
Deferred income taxes 3,097 - - - 3,097
Prepaid and other current assets 23,993 - 13,971 (4,362) 33,602
Total current assets 33,833 - 181,554 (4,362) 211,025
Property and equipment, net 9,829 - 160,066 - 169,895
Investments in unconsolidated affiliates and other 1,484,974 1,453,596 - (2,922,178) 16,392
Goodwill and intangible assets, net 20,684 - 978 1,758,970 1,780,632
Total assets $ 1,549,320$ 1,453,596$ 342,598$ (1,167,570)$ 2,177,944
Liabilities and Equity
Current liabilities:
Current portion of long-term debt $ 10,714$ -$ 10,130$ -$ 20,844
Accounts payable 1,972 - 29,487 (3,958) 27,501
Accrued liabilities 27,419 - 14,510 (404) 41,525
Total current liabilities 40,105 - 54,127 (4,362) 89,870
Long-term debt 561,429 - 53,246 (31,377) 583,298
Deferred income taxes 176,020 - - - 176,020
Other long-term liabilities 7,569 - 17,934 - 25,503
Noncontrolling interests – redeemable - - 63,704 113,993 177,697
Equity:
Total AmSurg Corp. equity 764,197 1,453,596 114,671 (1,568,267) 764,197
Noncontrolling interests – non-redeemable - - 38,916 322,443 361,359
Total equity 764,197 1,453,596 153,587 (1,245,824) 1,125,556
Total liabilities and equity $ 1,549,320$ 1,453,596$ 342,598$ (1,167,570)$ 2,177,944
Condensed Income Statement
Condensed Consolidating Statement of Earnings and Comprehensive Income - For the Three Months Ended March 31, 2014 (In thousands)
GuarantorNon-GuarantorConsolidatingTotal
Parent IssuerSubsidiariesSubsidiariesAdjustmentsConsolidated
Revenues$ 6,127$ -$ 261,589$ (4,609)$ 263,107
Operating expenses:
Salaries and benefits 14,485 - 68,830 (121) 83,194
Supply cost - - 38,720 - 38,720
Other operating expenses 4,166 - 55,591 (4,488) 55,269
Depreciation and amortization 825 - 7,549 - 8,374
Total operating expenses 19,476 - 170,690 (4,609) 185,557
Gain on deconsolidation 2,045 2,045 - (2,045) 2,045
Equity in earnings of unconsolidated affiliates 48,052 48,052 - (95,340) 764
Operating income 36,748 50,097 90,899 (97,385) 80,359
Interest expense 6,452 - 511 - 6,963
Earnings from continuing operations before income taxes 30,296 50,097 90,388 (97,385) 73,396
Income tax expense 12,704 - 353 - 13,057
Net earnings from continuing operations 17,592 50,097 90,035 (97,385) 60,339
Net earnings (loss) from discontinued operations (397) - 172 - (225)
Net earnings and comprehensive income 17,195 50,097 90,207 (97,385) 60,114
Less net earnings and comprehensive income attributable to noncontrolling interests:
Net earnings from continuing operations - - 42,835 - 42,835
Net earnings from discontinued operations - - 84 - 84
Total net earnings and comprehensive income attributable to noncontrolling interests - - 42,919 - 42,919
Net earnings and comprehensive income attributable to AmSurg Corp. common shareholders $ 17,195$ 50,097$ 47,288$ (97,385)$ 17,195
Amounts attributable to AmSurg Corp. common shareholders:
Earnings from continuing operations, net of income tax $ 17,592$ 50,097$ 47,200$ (97,385)$ 17,504
Discontinued operations, net of income tax (397) - 88 - (309)
Net earnings and comprehensive income attributable to AmSurg Corp. common shareholders $ 17,195$ 50,097$ 47,288$ (97,385)$ 17,195
Condensed Consolidating Statement of Earnings and Comprehensive Income - For the Three Months Ended March 31, 2013 (In thousands)
GuarantorNon-GuarantorConsolidatingTotal
Parent IssuerSubsidiariesSubsidiariesAdjustmentsConsolidated
Revenues$ 5,716$ -$ 256,711$ (4,238)$ 258,189
Operating expenses:
Salaries and benefits 15,421 - 65,650 (113) 80,958
Supply cost - - 37,213 - 37,213
Other operating expenses 5,060 - 51,792 (4,125) 52,727
Depreciation and amortization 772 - 7,236 - 8,008
Total operating expenses 21,253 - 161,891 (4,238) 178,906
Gain on deconsolidation 2,237 2,237 - (2,237) 2,237
Equity in earnings of unconsolidated affiliates 49,955 49,955 - (99,508) 402
Operating income 36,655 52,192 94,820 (101,745) 81,922
Interest expense 6,923 - 619 - 7,542
Earnings from continuing operations before income taxes 29,732 52,192 94,201 (101,745) 74,380
Income tax expense 11,877 - 392 - 12,269
Net earnings from continuing operations 17,855 52,192 93,809 (101,745) 62,111
Net earnings (loss) from discontinued operations (44) - 206 - 162
Net earnings and comprehensive income 17,811 52,192 94,015 (101,745) 62,273
Less net earnings and comprehensive income attributable to noncontrolling interests:
Net earnings from continuing operations - - 44,361 - 44,361
Net earnings from discontinued operations - - 101 - 101
Total net earnings and comprehensive income attributable to noncontrolling interests - - 44,462 - 44,462
Net earnings and comprehensive income attributable to AmSurg Corp. common shareholders $ 17,811$ 52,192$ 49,553$ (101,745)$ 17,811
Amounts attributable to AmSurg Corp. common shareholders:
Earnings from continuing operations, net of income tax $ 17,855$ 52,192$ 49,448$ (101,745)$ 17,750
Discontinued operations, net of income tax (44) - 105 - 61
Net earnings and comprehensive income attributable to AmSurg Corp. common shareholders $ 17,811$ 52,192$ 49,553$ (101,745)$ 17,811
Condensed Cash Flow Statement
Condensed Consolidating Statement of Cash Flows - For the Three Months Ended March 31, 2014 (In thousands)
ParentGuarantorNon-GuarantorConsolidatingTotal
IssuerSubsidiariesSubsidiariesAdjustmentsConsolidated
Cash flows from operating activities:
Net cash flows provided by operating activities $ 18,482$ 48,096$ 96,257$ (93,016)$ 69,819
Cash flows from investing activities:
Acquisition of interests in surgery centers and related transactions - (5,082) - 44 (5,038)
Acquisition of property and equipment (1,237) - (5,801) - (7,038)
Proceeds from sale of interests in surgery centers - 1,111 - - 1,111
Other (629) 211 - - (418)
Net cash flows used in investing activities (1,866) (3,760) (5,801) 44 (11,383)
Cash flows from financing activities:
Proceeds from long-term borrowings 30,000 - 1,945 - 31,945
Repayment on long-term borrowings (47,679) - (3,174) - (50,853)
Distributions to owners, including noncontrolling interests - (44,920) (91,290) 93,016 (43,194)
Changes in intercompany balances with affiliates, net 556 - (556) - -
Other financing activities, net (641) 584 43 (44) (58)
Net cash flows used in financing activities (17,764) (44,336) (93,032) 92,972 (62,160)
Net decrease in cash and cash equivalents (1,148) - (2,576) - (3,724)
Cash and cash equivalents, beginning of period 6,710 - 44,130 - 50,840
Cash and cash equivalents, end of period$ 5,562$ - $ 41,554$ - $ 47,116
Condensed Consolidating Statement of Cash Flows - For the Three Months Ended March 31, 2013 (In thousands)
ParentGuarantorNon-GuarantorConsolidatingTotal
IssuerSubsidiariesSubsidiariesAdjustmentsConsolidated
Cash flows from operating activities:
Net cash flows provided by operating activities $ 23,940$ 49,577$ 99,411$ (99,063)$ 73,865
Cash flows from investing activities:
Acquisition of interests in surgery centers and related transactions - (242) - (10) (252)
Acquisition of property and equipment (853) - (5,257) - (6,110)
Net cash flows used in investing activities (853) (242) (5,257) (10) (6,362)
Cash flows from financing activities:
Proceeds from long-term borrowings 29,700 - 1,170 - 30,870
Repayment on long-term borrowings (45,024) - (3,187) - (48,211)
Distributions to owners, including noncontrolling interests - (49,486) (93,491) 99,063 (43,914)
Changes in intercompany balances with affiliates, net 533 - (533) - -
Other financing activities, net (10,792) 151 398 10 (10,233)
Net cash flows used in financing activities (25,583) (49,335) (95,643) 99,073 (71,488)
Net decrease in cash and cash equivalents (2,496) - (1,489) - (3,985)
Cash and cash equivalents, beginning of period 7,259 - 39,139 - 46,398
Cash and cash equivalents, end of period$ 4,763$ - $ 37,650$ - $ 42,413